In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans

Mycoses

Volumn 49, Issue 3, 2006, Pages 159-168

  Sigle, H C ^a   Schafer Korting M ^b   Korting, H C ^c   Hube, B ^d   Niewerth, M ^c  

^a Kreiskliniken Traunstein/Trostberg GmbH   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Candida albicans; Hydroxypyridones; Piroctone; Rilopirox

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMPHOTERICIN B; ANTIFUNGAL AGENT; CLOTRIMAZOLE; FLUCYTOSINE; IRON; PIROCTONE ETHANOLAMINE; POLYENE ANTIBIOTIC AGENT; PYRIDONE DERIVATIVE; PYRROLE DERIVATIVE; REACTIVE OXYGEN METABOLITE; RILOPIROX;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; FUNGICIDAL ACTIVITY; FUNGISTASIS; FUNGUS HYPHAE; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CULTURE MEDIA; DRUG COMBINATIONS; ETHANOLAMINES; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIDONES; REACTIVE OXYGEN SPECIES;

CANDIDA ALBICANS; FUNGI;

EID: 33646269961     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01228.x     Document Type: Article

References (28)

1. Korting HC Grundmann-Kollmann M. The hydroxypyridones: a class of antimycotics of its own Mycoses 1997 40 243 7
2. Groll AH Piscitelli SC Walsh TJ. Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development Adv Pharmacol 1998 44 343 500
3. Gupta AK Sauder DN Shear NH. Antifungal agents: an overview (Part II) J Am Acad Dermatol 1994 30 911 33
4. Raether W Hänel H. Rilopirox - a new hydroxypyridone antifungal with fungicidal properties Mycoses 1990 33 191 202
5. Hrabé de Angelis M Dannhorn DR Hänel H Kirchner C. Effects of rilopirox on rabbit blastocysts in a protein-free in vitro culture under different culture conditions Drug Res 1994 44 674 8
6. Futterer E. Antidandruff hair tonic containing piroctone olamine Cosmet Toiletries 1988 15 49 52
7. Reitze HK Dannhorn DR Hänel H Seitz KA. Ultrastructural investigations of Candida albicans after in vitro treatment with the new fungicidal agent rilopirox Mycoses 1993 36 385 95
8. Braga PC Piatti G Conti E Vignali F. Effects of subinhibitory concentrations of ciclopirox on the adherence of Candida albicans to human buccal and vaginal epithelial cells Drug Res 1992 42 1368 71
9. Braga PC Dal Sasso M Maci S Piatti G Dannhorn DR Bohn M. Inhibition of Candida albicans adhesiveness to human buccal and vaginal cells by sub-inhibitory concentrations of rilopirox Drug Res 1995 45 84 7
10. Braga PC Maci S Dal Sasso M Bohn M. Experimental evidences for a role of subinhibitory concentrations of rilopirox, nystatin and fluconazole on adherence of Candida spp. to vaginal epithelial cells Chemotherapy 1996 42 259 65
11. Kruse R Hengstenberg W Hänel H Raether W. Studies for the elucidation of the mode of action of the antimycotic hydroxypyridone compound, rilopirox Pharmacology 1991 43 247 55
12. Niewerth M Schaller M Korting HC Hube B. Wirkungsweise von Ciclopiroxolamin auf Candida albicans (in German) Mycoses 2002 45 Suppl. 1 63 8
13. Niewerth M Kunze D Seibold M Schaller M Korting HC Hube B. Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors Antimicrob Agents Chemother 2003 47 1805 17
14. Lee KL Buckley HR Campbell CC. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of C. albicans Sabouraudia 1975 13 148 53
15. Dittmar W Lohaus G. HOE 296, a new antimycotic compound with a broad antimicrobial spectrum Drug Res 1973 23 670 4
16. Lohaus G Dittmar W. Zur Chemie von antimikrobiell wirksamen 1-Hydroxy-2-pyridonen (in German) Drug Res 1981 31 1311 6
17. Dittmar W Grau W Raether W Schrinner E Wagner WH. Mikrobiologische Laboruntersuchungen mit Ciclopiroxolamin (in German) Drug Res 1981 31 1317 22
18. Jue SG Dawson GW Brogden RN. Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use Drugs 1985 29 330 41
19. Nolting S Seebacher C. Antimykotisches Wirkspektrum (in German) In Nolting S Seebacher C eds Ciclopiroxolamin. Wegweiser topischer Mykose-Therapie Jena Universitätsverlag Jena 1993 73 5
20. Gupta AK Kohli Y. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity Br J Dermatol 2003 149 296 305
21. Kokjohn K Bradley M Griffiths BS Ghannoum M. Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria Int J Dermatol 2003 42 Suppl. 1 11 7
22. Sakurai K Sakaguchi T Yamaguchi H Iwata K. Studies on uptake of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296) by Candida albicans Chemotherapy 1978 24 146 53
23. Iwata K Yamaguchi H. Studies on the mechanism of antifungal action of ciclopiroxolamine Drug Res 1981 31 1323 7
24. Sakurai K Sakaguchi T Yamaguchi H Iwata K. Mode of action of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296) Chemotherapy 1978 24 68 76
25. Gasparini G Contini D Torti C Guigarelli C Lasagni A Caputo R. The effect of ciclopiroxolamine investigated by means of the freeze-fracture technique Mykosen 1986 29 539 44
26. Schaller M Krnjaic N Niewerth M Hamm G Hube B Korting HC. Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans J Med Microbiol 2003 52 247 9
27. Abrams BB Hänel H Hoehler T. Ciclopirox olamine: a hydroxypyridone antifungal agent Clin Dermatol 1992 9 471 7
28. Leem SH Park JE Kim IS Chae JY Sugino A Sunwoo Y. The possible mechanism of action of ciclopirox olamine in the yeast Saccharomyces cerevisiae Mol Cells 2003 15 55 61